About 100 reports

  • DEVELOPMENT OF ANTIBIOTIC RESISTANCE
  • SPREAD OF ANTIBIOTIC RESISTANCE
  • Antibiotic Resistance
  • Allergan plc
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Pfizer Inc.
  • 4.6.9 CONCLUSION
  • 2.7.2 MRSA

Antibiotic resistance genes have allowed bacteria to become capable of developing resistance to antibiotics through several mechanisms.

  • Antibiotic Resistance
  • World
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Pfizer Inc.
  • EQUITY OFFERING
  • Deal Type
  • Antibiotic Resistance
  • United States
  • Company
  • Demand
  • OpGen, Inc.
  • Hospital Acquired Methicillin-Resistant Staphylococcus aureus (HA-MRSA) Infections - Product...

" The figures highlighted in Jim O' Neill' s report - and in particular the potential human cost of not addressing antibiotic resistance - are significant.

  • Antibiotic Resistance
  • United Kingdom
  • World
  • Product Initiative
  • MGB Biopharma Limited
  • TOSATOXUMAB - DRUG PROFILE

The ERS notes that antibiotic resistance is one of the major threats undermining the treatment of respiratory infections.

  • Antibiotic Resistance
  • United States
  • World
  • Product Initiative
  • Cempra, Inc.

This approach is less susceptible to development of antibiotic resistance, can be used both therapeutically and prophylactically.

  • Antibiotic Resistance
  • Infectious Disease
  • United States
  • World
  • Product Initiative

Tetraphase Pharmaceuticals Inc (Tetraphase) is a clinical stage life science company that discovers and develops antibiotic resistance medicines.

  • Antibiotic Resistance
  • United States
  • World
  • Product Initiative
  • Soligenix, Inc.
  • Jul 27, 2016: CDC funding accelerates antibiotic resistance efforts
  • Oct 06, 2016: Penn Medicine Receives CDC Award to Combat Antibiotic Resistance
  • Antibiotic Resistance
  • Infectious Disease
  • Vaccine
  • United States
  • GlobalData's company
  • May 04, 2016: Bausch + Lomb Reports Preliminary 2015 Results of the Antibiotic Resistance...
  • May 10, 2017: Bausch + Lomb Reports Updated Results of the Antibiotic Resistance Monitoring...
  • Antibiotic Resistance
  • Eye Disease
  • Ophthalmology
  • United States
  • Bausch & Lomb Incorporated
  • Oct 06, 2016: Synthetic Biologics Awarded Research Contract from Centers for Disease Control...
  • Antibiotic Resistance
  • Digestive System Disorder
  • United States
  • World
  • Product Initiative
  • R&D Progress
  • SMALL MOLECULE TO INHIBIT DNA-DIRECTED RNA POLYMERASE SUBUNIT BETA AND HIV INTEGRASE FOR HIV...
  • Antibiotic Resistance
  • DNA
  • United States
  • World
  • Product Initiative
  • and study to combat antibiotic resistance
  • AMR
  • Anti-Infective
  • Antibiotic Resistance
  • Pharmaceutical
  • Therapy
  • United States

It will also additionally report major categories of antibiotic resistance mechanism present for each type of organism within a total of ##-## hours after receiving a specimen.

  • Antibiotic Resistance
  • Diagnostics
  • United States
  • Company Financials
  • Accelerate Diagnostics, Inc.

Irrational use of antibiotics causes the emergence of antibiotic resistance strains and increases the cost of healthcare.

  • Antibiotic Resistance
  • Allergan plc
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Sandoz Inc.
  • FEB 10, 2015: THERAVANCE BIOPHARMA INITIATES PATIENT REGISTRY STUDY FOR VIBATIV (TELAVANCIN)
  • AERUCIN - DRUG PROFILE

THESE ANTIBIOTIC COMBINATIONS UTILIZE NOVEXEL' S INVESTIGATIONAL BETA-LACTAMASE INHIBITOR NXL-## TO OVERCOME ANTIBIOTIC RESISTANCE.

  • Anti-Infective
  • Antibiotic Resistance
  • United States
  • Product Initiative
  • Aridis Pharmaceuticals LLC
  • Oct 06, 2016: Synthetic Biologics Awarded Research Contract from Centers for Disease Control...
  • Latest Clinical Trials News on Infectious Diarrhea
  • Antibiotic Resistance
  • Digestive System Disorder
  • Therapy
  • World
  • Product Initiative
  • ANTIBIOTIC RESISTANCE MARKER CARTRIDGE
  • Antibiotic Resistance Marker Cartridge - Product Status
  • Antibiotic Resistance
  • China
  • Europe
  • United States
  • Curetis N.V.

The emerging multi-drug resistant bacterium is a type of carbapenem-resistant Enterobacteriaceae (CRE) that presents with an antibiotic resistance profile that is different than other types of CRE.

  • Antibiotic Resistance
  • Biotechnology
  • In Vitro Diagnostic Reagent
  • Nanobiotechnology
  • Nanosphere, Inc.
  • CAL-02 - DRUG PROFILE

Antibiotic resistance rates are on the rise and there is a growing need for new treatment options for people with serious infections. "

  • Antibiotic Resistance
  • Infectious Disease
  • World
  • Product Initiative
  • GlaxoSmithKline plc
  • Oct 06, 2016: Synthetic Biologics Awarded Research Contract from Centers for Disease Control...
  • Antibiotic Resistance
  • Digestive System Disorder
  • United States
  • Product Initiative
  • Synthetic Biologics

The company intends to use the proceeds to complete the product development and market introduction of BACcel, a culture-free diagnostic system for same-shift identification and antibiotic resistance testing of bacterial and fungal pathogens.

  • Antibiotic Resistance
  • United States
  • Company
  • Corporate Finance
  • Accelerate Diagnostics, Inc.
  • SMALL MOLECULES TO INHIBIT LETHAL FACTOR FOR ANTHRAX AND CYSTIC FIBROSIS - DRUG PROFILE
  • ANTHRAX - PIPELINE BY VLP BIOTECH INC, H2 2017

Department of Health and Human Services Biomedical Advanced Research and Development Authority (BARDA) and GlaxoSmithKline of North Carolina entered into an agreement to develop antibiotics to combat bioterrorism and antibiotic resistance.

  • Antibiotic Resistance
  • Infectious Disease
  • Vaccine
  • United States
  • Product Initiative
  • JUN 05, 2015: TAXIS PHARMACEUTICALS ANNOUNCES PUBLICATION OF DATA DEMONSTRATING POTENTIAL VIABILITY...
  • APR 27, 2015: TAXIS PHARMACEUTICALS DEMONSTRATES CLINICAL POTENTIAL OF TXA709 IN COMBATING...
  • Anti-Infective
  • Antibiotic Resistance
  • United States
  • World
  • Product Initiative
  • HOSPITAL ACQUIRED METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS (HA-MRSA) INFECTIONS
  • PSEUDOMONAS AERUGINOSA INFECTIONS - PIPELINE BY SANOFI,

" Antibiotic resistance to current therapies is at an all-time high.

  • Antibiotic Resistance
  • Infectious Disease
  • Pharmaceutical
  • Vaccine
  • AstraZeneca PLC
  • ATLAS IO SYSTEM - BACTERIAL IDENTIFICATION AND ANTIBIOTIC RESISTANCE
  • ATLAS IO SYSTEM - BACTERIAL IDENTIFICATION AND ANTIBIOTIC RESISTANCE - PRODUCT STATUS
  • Antibiotic Resistance
  • Sexually Transmitted Disease
  • United Kingdom
  • United States
  • GlobalData's company

" Growing antibiotic resistance is a worldwide health issue", explains Nigel McCraken, Vice President, Translational Medicine of Debiopharm International SA.

  • Antibiotic Resistance
  • Sexually Transmitted Disease
  • United States
  • Product Initiative
  • Cempra, Inc.
  • MOUNTING THREAT OF MICROBIAL ANTIBIOTIC RESISTANCE
  • MOUNTING THREAT OF MICROBIAL ANTIBIOTIC RESISTANCE
  • Antibiotic Resistance
  • United States
  • Alere Inc.
  • Cepheid
  • Roche Group
  • SMALL MOLECULES TO INHIBIT LETHAL FACTOR FOR ANTHRAX AND CYSTIC FIBROSIS - DRUG PROFILE
  • SYNTIRON LLC

SYNTIRON LLC Tetraphase Pharmaceuticals Inc (Tetraphase) is a clinical stage life science company that discovers and develops antibiotic resistance medicines.

  • Antibiotic Resistance
  • Biotech
  • United States
  • Product Initiative
  • Cempra, Inc.
  • GEPOTIDACIN MESYLATE - DRUG PROFILE

Department of Health and Human Services Biomedical Advanced Research and Development Authority (BARDA) and GlaxoSmithKline of North Carolina entered into an agreement to develop antibiotics to combat bioterrorism and antibiotic resistance.

  • Antibiotic Resistance
  • Infectious Disease
  • Vaccine
  • United States
  • Product Initiative

Golparian et al. tested the activity of solithromycin against clinical isolates of N. gonorrhoeae that displayed a variety of antibiotic resistance profiles.

  • Anti-Infective
  • Antibiotic Resistance
  • United States
  • Product Initiative
  • Cempra, Inc.